EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Process engineering of natural killer cell-based immunotherapy

Pedram Motallebnejad, Anne Kantardjieff, Frank Cichocki, Samira M Azarin, Wei-Shou Hu

Trends in Biotechnology · 2023-10 · 41 (10) · 1314-1326

DOI: 10.1016/j.tibtech.2023.03.018 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Biotechnology, 2023-10. Verfasst von Pedram Motallebnejad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, MN 55455, USA. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Science Foundation, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cell therapy offers the potential for curative treatment of cancers. Although T cells have been the predominantly used cell type, natural killer (NK) cells have attracted great attention owing to their ability to kill cancer cells and because they are naturally suitable for allogeneic applications. Upon stimulation by cytokines or activation by a target cell, NK cells proliferate and expand their population. These cytotoxic NK cells can be cryopreserved and used as an off-the-shelf medicine. The production process for NK cells thus differs from that of autologous cell therapies. We briefly outline key biological features of NK cells, review the manufacturing technologies for protein biologics, and discuss their adaptation for developing robust NK cell biomanufacturing processes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunotherapy, AdoptiveNeoplasmsHumansKiller Cells, NaturalImmunotherapyT-Lymphocytes

Stichwörter der Autor:innen

biomanufacturingbioreactornatural killer cellprocess analytical technologyquality by designscale-up

Autor:innen und Institutionen

  • Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, MN 55455, USA.
  • Bluebird Bio, Cambridge, MA 02142, USA.
  • Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
  • Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: wshu@umn.edu.

Förderung

  • NHLBI NIH HHS
  • National Science Foundation
  • National Institutes of Health

Zitieren

APA

Motallebnejad, P., Kantardjieff, A., Cichocki, F., Azarin, S. M., & Hu, W. S. (2023). Process engineering of natural killer cell-based immunotherapy. Trends in Biotechnology, 41(10), 1314-1326. https://doi.org/10.1016/j.tibtech.2023.03.018

Vancouver

Motallebnejad P, Kantardjieff A, Cichocki F, Azarin SM, Hu WS. Process engineering of natural killer cell-based immunotherapy. Trends in Biotechnology. 2023;41(10):1314-1326. doi:10.1016/j.tibtech.2023.03.018

BibTeX
@article{Motallebnejad2023,
  author = {Motallebnejad, Pedram and Kantardjieff, Anne and Cichocki, Frank and Azarin, Samira M and Hu, Wei-Shou},
  title = {Process engineering of natural killer cell-based immunotherapy},
  journal = {Trends in Biotechnology},
  year = {2023},
  volume = {41},
  number = {10},
  pages = {1314--1326},
  doi = {10.1016/j.tibtech.2023.03.018}
}
Kostenlos starten →